Xadovild M 500mg/50mg Tablet

The synergistic action of these agents helps in achieving better glycemic control compared to monotherapy, reducing fasting and postprandial blood glucose levels. Xadovild M is typically prescribed as an adjunct to diet and exercise in patients inadequately controlled on either component alone or when combination therapy is deemed appropriate. It is important to monitor renal function prior to and during treatment, as Metformin is contraindicated in patients with significant renal impairment.

Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, while Vildagliptin is generally well tolerated but may rarely cause hypersensitivity reactions. Regular blood glucose monitoring and adherence to prescribed lifestyle modifications enhance therapeutic outcomes with Xadovild M.